SSY Group Limited (2005.HK)

HKD 3.31

(-2.93%)

Total Liabilities Summary of SSY Group Limited

SSY Group Limited's latest annual total liabilities in 2023 was 4.49 Billion HKD , up 5.48% from previous year.
SSY Group Limited's latest quarterly total liabilities in 2024 Q2 was 4.97 Billion HKD , down 0.0% from previous quarter.
SSY Group Limited reported annual total liabilities of 4.26 Billion HKD in 2022, up 3.75% from previous year.
SSY Group Limited reported annual total liabilities of 4.1 Billion HKD in 2021, up 26.67% from previous year.
SSY Group Limited reported quarterly total liabilities of 4.49 Billion HKD for 2023 FY, up 5.48% from previous quarter.
SSY Group Limited reported quarterly total liabilities of 4.49 Billion HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of SSY Group Limited (2023 - 2004)

Historical Annual Total Liabilities of SSY Group Limited (2023 - 2004)

Year	Total Liabilities	Total Liabilities Growth
2023	4.49 Billion HKD	5.48%
2022	4.26 Billion HKD	3.75%
2021	4.1 Billion HKD	26.67%
2020	3.24 Billion HKD	30.66%
2019	2.48 Billion HKD	-0.86%
2018	2.5 Billion HKD	3.53%
2017	2.41 Billion HKD	17.36%
2016	2.05 Billion HKD	-21.17%
2015	2.61 Billion HKD	69.18%
2014	1.54 Billion HKD	-30.33%
2013	2.21 Billion HKD	47.57%
2012	1.5 Billion HKD	30.84%
2011	1.14 Billion HKD	12.97%
2010	1.01 Billion HKD	16.24%
2009	874.43 Million HKD	-23.41%
2008	1.14 Billion HKD	30.27%
2007	876.35 Million HKD	112.98%
2006	411.47 Million HKD	24.79%
2005	329.74 Million HKD	-20.39%
2004	414.18 Million HKD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	4.97 Billion HKD	0.0%
2023 FY	4.49 Billion HKD	5.48%
2023 Q4	4.49 Billion HKD	0.0%
2023 Q2	4.45 Billion HKD	0.0%
2022 Q4	4.26 Billion HKD	0.0%
2022 FY	4.26 Billion HKD	3.75%
2022 Q2	4.45 Billion HKD	0.0%
2021 FY	4.1 Billion HKD	26.67%
2021 Q4	4.1 Billion HKD	0.0%
2021 Q2	3.45 Billion HKD	0.0%
2020 Q2	2.85 Billion HKD	0.0%
2020 FY	3.24 Billion HKD	30.66%
2020 Q4	3.24 Billion HKD	0.0%
2019 Q2	2.53 Billion HKD	0.0%
2019 Q4	2.48 Billion HKD	0.0%
2019 FY	2.48 Billion HKD	-0.86%
2018 Q4	2.5 Billion HKD	0.0%
2018 FY	2.5 Billion HKD	3.53%
2018 Q2	1.85 Billion HKD	0.0%
2017 Q4	2.41 Billion HKD	0.0%
2017 FY	2.41 Billion HKD	17.36%
2017 Q2	2.11 Billion HKD	0.0%
2016 Q4	2.05 Billion HKD	0.0%
2016 FY	2.05 Billion HKD	-21.17%
2016 Q2	2.32 Billion HKD	0.0%
2015 FY	2.61 Billion HKD	69.18%
2015 Q4	2.61 Billion HKD	0.0%
2015 Q2	1.92 Billion HKD	0.0%
2014 Q2	2.41 Billion HKD	0.0%
2014 Q4	1.54 Billion HKD	0.0%
2014 FY	1.54 Billion HKD	-30.33%
2013 Q4	2.21 Billion HKD	0.0%
2013 Q2	1.79 Billion HKD	0.0%
2013 FY	2.21 Billion HKD	47.57%
2012 FY	1.5 Billion HKD	30.84%
2012 Q2	1.27 Billion HKD	0.0%
2012 Q4	1.5 Billion HKD	0.0%
2011 Q4	1.14 Billion HKD	0.0%
2011 FY	1.14 Billion HKD	12.97%
2011 Q2	911.03 Million HKD	0.0%
2010 Q4	1.01 Billion HKD	0.0%
2010 Q2	863.87 Million HKD	0.0%
2010 FY	1.01 Billion HKD	16.24%
2009 Q4	874.43 Million HKD	0.0%
2009 FY	874.43 Million HKD	-23.41%
2008 FY	1.14 Billion HKD	30.27%
2007 FY	876.35 Million HKD	112.98%
2006 FY	411.47 Million HKD	24.79%
2005 FY	329.74 Million HKD	-20.39%
2004 FY	414.18 Million HKD	0.0%

Peer Total Liabilities Comparison of SSY Group Limited

Name	Total Liabilities	Total Liabilities Difference
Pak Fah Yeow International Limited	142.28 Million HKD	-3058.467%
Grand Pharmaceutical Group Limited	7.24 Billion HKD	37.97%
Extrawell Pharmaceutical Holdings Limited	170.4 Million HKD	-2537.175%
Wai Yuen Tong Medicine Holdings Limited	709.65 Million HKD	-533.256%
Qianhai Health Holdings Limited	94 Million HKD	-4680.624%
Lee's Pharmaceutical Holdings Limited	930.06 Million HKD	-383.182%
Essex Bio-Technology Limited	903.78 Million HKD	-397.236%
Tongfang Kontafarma Holdings Limited	665.38 Million HKD	-575.384%
PuraPharm Corporation Limited	689.65 Million HKD	-551.624%
JBM (Healthcare) Limited	366.75 Million HKD	-1125.329%
Jacobson Pharma Corporation Limited	1.09 Billion HKD	-312.1%
China Resources Pharmaceutical Group Limited	168.46 Billion HKD	97.332%